About
Oncology Treatments
Areas of Focus
Categories
San Diego & Southern California
Team (56)
Aaron Davis
Co-Founder & CEO, Boxer Capital
Alterome Therapeutics
executivefounder
America Thompson
VP, Head of Finance
Alterome Therapeutics
executive
Andrew Chi
CMO
Alterome Therapeutics
executive
Andrew Phimister
VP, Formulation and Drug Product
Alterome Therapeutics
executive
Annie Huynh
Clinical Trial Manager
Alterome Therapeutics
team_member
Artie Zaragoza
Sr Manager, Finance & Accounting
Alterome Therapeutics
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
240
By Phase
PHASE1: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06835569Lead Sponsor
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
PHASE1Recruiting
130 participants
Started: Mar 5, 2025 · Completed: Aug 31, 2029
NCT06533059Lead Sponsor
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
PHASE1Recruiting
110 participants
Started: Aug 22, 2024 · Completed: Dec 29, 2027
Funding History (1)
D
Jan 14, 2022
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...